Gaining mechanistic insights into the molecular mechanism of CCR9-SREBF2 in boosting cholesterol biosynthesis would be an exciting future research avenue in the relatively new era of T-ALL cholesterol metabolism. This evidence concerns the gene CCR9 and acute lymphoblastic leukemia.